The Harvard motor neurone disease drug developer secured Mitsui, Sanford Biosciences and existing backer Amgen Ventures for its series A round.
Author: Callum Cyrus
Featurespace impresses for $36.8m round
Featurespace, a Cambridge spinout, has boosted its funding total to $108m though Worldpay did not return for the latest round.
Shift hits play on $70m fund
The fund is expected to close by year end with LPs including Protix and a range of unnamed companies, as well as multiple universities.
Kurma sets the stage for $175m fund
Life sciences-focused venture firm Kurma Partners has secured Servier Laboratories for a third fund dedicated to early and incubation-stage therapeutics companies.
Federated Wireless extends series C round
The mobile frequency technology provider added $13.7m to an SBA Communications and American Tower-backed round now sized at $64.7m.
Actym Therapeutics actions $34m series A
Boehringer Ingelheim Venture Fund co-led the cancer immunotherapy developer’s series A round, which also featured Illumina Ventures.
Novo kicks in series A funding for Kebotix
The Baidu-backed advanced chemicals developer secured $11.4m in a series A round featuring Novo with a targeted close of $15m.
Nelumbo nets another $14m for series A round
Danfoss helped Nelumbo, a developer of technology that improves the performance of HVAC systems, increase its series A round to $19.5m.
Insight Lifetech inhales series B-plus funding
The SiBionics-backed heart disease device developer secured $28.4m in a round led by SDIC Gaoxin Industrial Investment.
Fusion Pharmaceuticals fetches $20m
Canada Pension Plan Investment Board has pledged up to $20m for the Varian Medical and Johnson & Johnson-backed oncology drug developer.
Eyevensys earns $30m in series B
The eye disease drug developer has closed a round led by existing backer Boehringer Ingelheim Venture Fund to take its total funding above $42m.
Oxford Nanopore extracts more funding
The Illumina and Amgen-backed genetic sequencing system developer raised $38.5m while its shareholders sold another $106m in shares.
Operator Collective attracts Bloomberg for $45m fund
Bloomberg Beta is one of more than 100 contributors to the oversubcribed inaugural fund raised by diversity-focused venture firm Operator Collective.
Apple spots Spectral Edge in acquisition deal
Apple paid an undisclosed amount for the mobile photo-enhancement technology developer, which had received nearly $8m in funding from investors including Martlet.